Christina S McCrae1, Ashley F Curtis2, Jacob M Williams3, Natalie D Dautovich4, Joseph P H McNamara5, Ashley Stripling6, Joseph M Dzierzewski4, Wai Sze Chan7, Richard B Berry8, Karin J M McCoy9, Michael Marsiske10. 1. Department of Psychiatry, University of Missouri-Columbia, Columbia, MO, USA. Electronic address: mccraec@health.missouri.edu. 2. Department of Psychiatry, University of Missouri-Columbia, Columbia, MO, USA. 3. TIRR Memorial Hermann, Houston, TX, USA. 4. Psychology Department, Virginia Commonwealth University, Richmond, VA, USA. 5. Department of Psychiatry, University of Florida, Gainesville, FL, USA. 6. College of Psychology, Nova Southeastern University, Fort Lauderdale, FL, USA. 7. Department of Psychiatry, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA. 8. College of Medicine, University of Florida, Gainesville, FL, USA. 9. Neuropsychology Service, South Texas Veterans Health Care System, San Antonio, TX, USA. 10. Department of Clinical and Health Psychology, University of Florida, Gainesville, FL, USA.
Abstract
OBJECTIVE: The aim of the present study was to examine the effects of a brief behavioral intervention for insomnia (BBTi) on sleep parameters, mood, and cognitive functioning in older adults. METHODS:Older adults (aged 65 years or more) underwent four weekly sessions of BBTi or self-monitoring control (SMC). Participants completed 14 days of sleep diaries and actigraphy measuring sleep onset latency (SOL), wake after sleep onset (WASO), total sleep time (TST), sleep efficiency (SE), and sleep quality ratings at baseline, post-treatment, and three month follow-up. Participants also completed mood scales (Geriatric Depression Scale [GDS]; Beck Depression Inventory-II; and State Trait Anxiety Inventory) and neuropsychological testing (measuring global cognition, language, memory, attention and processing speed, and executive function) at the three timepoints. RESULTS:Significant condition (BBTi vs. SMC) x time (baseline vs. post-treatment vs. follow-up) interactions revealed that BBTi improved relative to baseline in sleep diary-reported SOL, WASO, SE, and sleep quality, and these improvements were maintained at follow-up. SMC showed no change in these measures. A main effect of time showed that actigraphy-measured WASO improved from baseline for both BBTi and SMC at post-treatment. A main effect of time revealed that both BBTi and SMC patients endorsed fewer GDS symptoms relative to baseline at post-treatment and follow-up. We observed no change in performance on neuropsychological measures. CONCLUSIONS: A four-week BBTi is an efficacious intervention for reducing insomnia symptoms in older adults. BBTi does not selectively improve mood or cognitive functioning. Future work should examine effects of BBTi on physiological measures of sleep architecture and day-to-day cognition. CLINICAL TRIAL IDENTIFER: NCT02967185.
RCT Entities:
OBJECTIVE: The aim of the present study was to examine the effects of a brief behavioral intervention for insomnia (BBTi) on sleep parameters, mood, and cognitive functioning in older adults. METHODS: Older adults (aged 65 years or more) underwent four weekly sessions of BBTi or self-monitoring control (SMC). Participants completed 14 days of sleep diaries and actigraphy measuring sleep onset latency (SOL), wake after sleep onset (WASO), total sleep time (TST), sleep efficiency (SE), and sleep quality ratings at baseline, post-treatment, and three month follow-up. Participants also completed mood scales (Geriatric Depression Scale [GDS]; Beck Depression Inventory-II; and State Trait Anxiety Inventory) and neuropsychological testing (measuring global cognition, language, memory, attention and processing speed, and executive function) at the three timepoints. RESULTS: Significant condition (BBTi vs. SMC) x time (baseline vs. post-treatment vs. follow-up) interactions revealed that BBTi improved relative to baseline in sleep diary-reported SOL, WASO, SE, and sleep quality, and these improvements were maintained at follow-up. SMC showed no change in these measures. A main effect of time showed that actigraphy-measured WASO improved from baseline for both BBTi and SMC at post-treatment. A main effect of time revealed that both BBTi and SMCpatients endorsed fewer GDS symptoms relative to baseline at post-treatment and follow-up. We observed no change in performance on neuropsychological measures. CONCLUSIONS: A four-week BBTi is an efficacious intervention for reducing insomnia symptoms in older adults. BBTi does not selectively improve mood or cognitive functioning. Future work should examine effects of BBTi on physiological measures of sleep architecture and day-to-day cognition. CLINICAL TRIAL IDENTIFER: NCT02967185.
Authors: Daniel J Taylor; Laurel J Mallory; Kenneth L Lichstein; H Heith Durrence; Brant W Riedel; Andrew J Bush Journal: Sleep Date: 2007-02 Impact factor: 5.849
Authors: Christina S McCrae; Ashley F Curtis; Jacob M Williams; Natalie D Dautovich; Joseph P H McNamara; Ashley Stripling; Joseph M Dzierzewski; Richard B Berry; Karin M McCoy; Michael Marsiske Journal: Behav Sleep Med Date: 2019-06-15 Impact factor: 2.964
Authors: Wai Sze Chan; Natalie D Dautovich; Joseph P H McNamara; Ashley Stripling; Joseph M Dzierzewski; Karin McCoy; Christina S McCrae Journal: Behav Sleep Med Date: 2020-02-10 Impact factor: 2.964
Authors: Jack D Edinger; J Todd Arnedt; Suzanne M Bertisch; Colleen E Carney; John J Harrington; Kenneth L Lichstein; Michael J Sateia; Wendy M Troxel; Eric S Zhou; Uzma Kazmi; Jonathan L Heald; Jennifer L Martin Journal: J Clin Sleep Med Date: 2021-02-01 Impact factor: 4.062